Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
FASEB journal : official publication of the Federation of American Societies for Experimental Biology • 2017 | View Paper
“Pretreatment of HF myocytes with a nitric oxide (NO) synthase inhibitor L-NAME , 10−5 M) resulted in a significantly greater increase in ICa, L (28%, 8.4 ± 0.1 versus 6.5 ± 0.1 pA/pF, p < 0.01) during Ang-(1-7) superfusion.”
Therapeutic advances in cardiovascular disease • 2015 | View Paper
“Contrary to our expectation, L-NAME enhanced (p < 0.05) the exercise-induced Hsp72 content (EL vs. C, L and E groups = 1019%, 548% and 457%, respectively).”
Cellular Physiology and Biochemistry • 2011 | View Paper
“The small biphasic insulin secretion induced by L-leucine (5 mM) was also strongly enhanced, by 8 times, in the presence of L-NAME (5 mM) vs 2 times in the presence of D-NAME (5 mM).”